Partner notification to prevent pelvic inflammatory disease in women - Cost-effectiveness of two strategies

被引:40
作者
Howell, MR
Kassler, WJ
Haddix, A
机构
[1] CTR DIS CONTROL,NATL CTR PREVENT SERV,DIV STD PREVENT,ATLANTA,GA 30333
[2] CTR DIS CONTROL & PREVENT,NATL CTR PREVENT SERV,EPIDEMIOL PROGRAM OFF,PREVENT EFFECTIVENESS ACT,ATLANTA,GA
关键词
D O I
10.1097/00007435-199705000-00010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background and Objectives: Partner notification is an important strategy for prevention of Chlamydia trachomatis infection and pelvic inflammatory disease (PID), PID can be prevented by early diagnosis and treatment of the female sex partners of men infected with C. trachomatis (strategy 1) and by preventing reinfection in women through diagnosis and treatment of their male sex partners (strategy 2), Study Design: Using a decision model, the cost-effectiveness of strategies 1 and 2 was compared to no partner notification, Outcomes were measured by cases of PID prevented and net costs expended from a health care system perspective, Results: In a hypothetical cohort of 1,000 male and 1,000 female index patients, strategy 1 prevented 64 and strategy 2 prevented 20 cases of PID, Strategy 1 saved $247,000 and strategy 2 saved $33,000 over no partner notification, Sensitivity analysis showed that strategy 1 was cost-effective across a wide range of assumptions, Strategy 2 was cost-effective at baseline, but its cost-saving ability was subject to changes in the model, Conclusion: Partner notification of both male and female index patients is a cost-effective public health strategy for prevention of PID, In most settings, both strategies can and should be implemented.
引用
收藏
页码:287 / 292
页数:6
相关论文
共 26 条
[1]  
ALARY M, 1991, CAN J PUBLIC HEALTH, V82, P132
[2]   ATYPICAL PELVIC INFLAMMATORY DISEASE - CAN WE IDENTIFY CLINICAL PREDICTORS [J].
CATES, W ;
JOESOEF, MR ;
GOLDMAN, MB .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (02) :341-346
[3]   GENITAL CHLAMYDIAL INFECTIONS - EPIDEMIOLOGY AND REPRODUCTIVE SEQUELAE [J].
CATES, W ;
WASSERHEIT, JN .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (06) :1771-1781
[4]  
CUMINING DC, 1988, INT J FERTIL, V33, P324
[5]   CHLAMYDIA-TRACHOMATIS INFECTION IN A GYNECOLOGY CLINIC POPULATION - IDENTIFICATION OF HIGH-RISK GROUPS AND THE VALUE OF CONTACT TRACING [J].
FISH, ANJ ;
FAIRWEATHER, DVI ;
ORIEL, JD ;
RIDGWAY, GL .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1989, 31 (01) :67-74
[6]  
FOREST JD, 1989, NEED AVAILABILITY FI
[7]  
FUCHS VR, 1986, JAMA-J AM MED ASSOC, V225, P76
[8]   THE COST-EFFECTIVENESS OF AZITHROMYCIN FOR CHLAMYDIA-TRACHOMATIS INFECTIONS IN WOMEN [J].
HADDIX, AC ;
HILLIS, SD ;
KASSLER, WJ .
SEXUALLY TRANSMITTED DISEASES, 1995, 22 (05) :274-280
[9]  
HAMMERSCHLAG MR, 1979, PEDIATRICS, V64, P142
[10]   Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease [J].
Hillis, SD ;
Owens, LM ;
Marchbanks, PA ;
Amsterdam, LE ;
MacKenzie, WR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (01) :103-107